Does concomitant use of magnesium glycinate and furosemide cause a drug‑drug interaction, and how can it be avoided?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Drug-Drug Interaction Between Magnesium Glycinate and Furosemide

Yes, taking magnesium glycinate and furosemide together creates a clinically significant interaction where furosemide causes substantial magnesium wasting that directly counteracts magnesium supplementation, but this interaction should be managed through monitoring and dose adjustment rather than avoided entirely.

The Core Problem: Furosemide-Induced Magnesium Depletion

Furosemide causes significant urinary magnesium loss through its action on the loop of Henle, where most magnesium reabsorption occurs 1. Loop diuretics like furosemide are documented to cause substantial loss of both magnesium and potassium in plasma and intracellular spaces 2. The FDA label explicitly warns that furosemide may lower serum magnesium levels and requires periodic monitoring of these electrolytes 1.

Multiple guidelines confirm this mechanism:

  • The 2007 Canadian Cardiovascular Society guidelines identify magnesium or potassium deficiency (due to chronic loss from diuretics) as a key cause of diuretic resistance 3
  • The 2005 and 2009 ACC/AHA guidelines state that diuretics can cause depletion of important cations (potassium and magnesium), which can predispose patients to serious cardiac arrhythmias 4, 5, 6

Why This Matters Clinically

The interaction is bidirectional and clinically important:

  1. Furosemide undermines magnesium supplementation: Furosemide increases renal magnesium excretion, making it harder to maintain adequate magnesium levels even with supplementation 7, 8

  2. Magnesium deficiency reduces furosemide effectiveness: The guidelines explicitly note that magnesium deficiency is a cause of diuretic resistance 3. This creates a vicious cycle where furosemide depletes magnesium, and low magnesium makes furosemide less effective

  3. Cardiovascular risks: Magnesium deficiency increases risk of cardiac arrhythmias, particularly when combined with digitalis therapy 4, 5, 6. Magnesium is essential for maintaining intracellular potassium concentration 2

Management Strategy: Monitor and Adjust, Don't Avoid

The solution is NOT to avoid taking them together, but to implement proper monitoring and potentially higher magnesium doses:

1. Monitoring Protocol

  • Check serum electrolytes (particularly magnesium and potassium) frequently during the first few months of furosemide therapy 1
  • With any significant diuretic adjustment, repeat electrolyte measurements within 7 days (or 1-3 days in advanced heart failure) 3
  • Continue periodic monitoring every 3-6 months thereafter 9

Critical caveat: Serum magnesium levels poorly reflect total body magnesium status since magnesium is primarily intracellular 2. Consider clinical symptoms of deficiency even with "normal" serum levels.

2. Magnesium Supplementation Approach

  • Magnesium glycinate may be particularly appropriate in this setting because it has alternative absorption pathways compared to magnesium oxide 10
  • Research shows oral magnesium supplementation (300 mg/day magnesium citrate) in furosemide-treated heart failure patients significantly increased intracellular magnesium and serum potassium 11
  • Higher doses may be needed to overcome furosemide-induced losses—one case report used high-dose magnesium glycinate successfully in a patient with renal magnesium wasting 10

3. Consider Potassium-Sparing Diuretics

If you're also on other medications or have recurrent hypomagnesemia:

  • Amiloride has documented magnesium-sparing effects when combined with furosemide 8
  • However, the 2001 European guidelines note that potassium-sparing diuretics with ACE inhibitors require careful monitoring for hyperkalemia 9

4. Timing Considerations

  • Unlike some drug interactions (e.g., furosemide and sucralfate should be separated by 2 hours 1), there's no evidence that separating magnesium glycinate and furosemide dosing times provides benefit
  • The issue is chronic magnesium wasting, not acute absorption interference

Common Pitfalls to Avoid

  1. Don't assume normal serum magnesium means adequate stores: Intracellular magnesium can be depleted even with normal serum levels 2

  2. Don't stop magnesium supplementation just because you're on furosemide: The evidence supports that supplementation is beneficial and can improve both magnesium status and potassium levels 11

  3. Don't ignore symptoms of hypomagnesemia: Muscle weakness, cramps, cardiac arrhythmias, and refractory hypokalemia may indicate magnesium deficiency requiring treatment

  4. Watch for the cascade effect: Magnesium deficiency impairs potassium retention, so persistent hypokalemia despite potassium supplementation suggests underlying hypomagnesemia 2, 8

The Bottom Line

Continue both medications but implement rigorous electrolyte monitoring and be prepared to use higher magnesium doses than typical. The interaction is real and clinically significant, but the solution is management through monitoring and dose adjustment, not avoidance. Magnesium glycinate is actually a reasonable choice in this setting given its absorption characteristics 10.

References

Research

Heart failure and electrolyte disturbances.

Methods and findings in experimental and clinical pharmacology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.